Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island for Monday's 'Best and Brightest Forum on Medical Innovation,' with Rep. Patrick Kennedy, Other State Biotech Leaders

Thursday, December 10, 2009 General News
Email Print This Page Comment bookmark
Font : A-A+

PROVIDENCE, R.I., Dec. 9 As efforts to build Rhode Island's biotech, life sciences and medical innovation industries advance, Former House Majority Leader Richard Gephardt, Chairman of the Council for American Medical Innovation, will convene a two-hour panel discussion in Providence on Monday, December 14th with leading Rhode Island biotech and medical innovation experts to discuss the public policy underpinnings of a robust medical innovation industry, both nationally and here in Rhode Island.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090325/DC89081LOGO)

WHO:

WHAT: The Best and Brightest Forum on Medical Innovation, sponsored by the Council for American Medical Innovation and the New England Biotech Association, will take place at the Brown University Medical Research Facility, in the heart of what is hoped to become Providence's Knowledge District, a bustling hub of high tech medical research jobs that helps fuel the reshaping of Rhode Island's economy.

WHEN:

Monday, December 14, 2009

10:00 am - 12:00 pm

WHERE:

Brown University Medical Research Facility

70 Ship Street, Providence, RI 02903

-- Former House Majority Leader Richard Gephardt, Chairman, Council for American Medical Innovation -- Patrick Kennedy (D-RI), United States Congress -- Leonard Bell, Ph.D., CEO, Alexion Pharmaceuticals, Inc. -- David N. Cicilline, Mayor, Providence, RI -- Patrice Dudley-Aviles, Director, Human Resources, Amgen -- Steve Evangelista, President and CEO, Arthritis Foundation of Northern and Southern New England -- George Nee, President, RI AFL-CIO -- Peter Snyder, Ph.D., Vice President of Research, Lifespan -- Edward J. Wing, M.D., Dean, Brown University Medical School

SOURCE Council for American Medical Innovation


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook